Back
Corvus Pharmaceuticals, Inc. 10K Form
Sell
41
CRVS
Corvus Pharmaceuticals, Inc.
Last Price:
$8.81
Seasonality Move:
-12.72%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CRVS News And Ratings
See the #1 stock for the next 7 days that we like better than CRVS
CRVS Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-9.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.96 |
| Price / Book: | 8.78 |
Profitability
| EPS (TTM): | -0.53480 |
|---|---|
| Net Income (TTM): | $-15.1M |
| Gross Margin: | $-85K |
| Return on Equity: | -30.6% |
| Return on Assets: | -21.11% |
Corvus Pharmaceuticals, Inc. Earnings Forecast
Key Corvus Pharmaceuticals, Inc. Financial Ratios
-
Per Share Earnings over the last 10 years have been positive in 5 years.
Corvus Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CRVS |
| CUSIP: | 221015 |
| Website: | corvuspharma.com |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 8.29 |
| Quick Ratio: | 8.14 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CRVS Technical Analysis vs Fundamental Analysis
Sell
41
Corvus Pharmaceuticals, Inc. (CRVS)
is a Sell
Is Corvus Pharmaceuticals, Inc. a Buy or a Sell?
-
Corvus Pharmaceuticals, Inc. stock is rated a SellThe current Corvus Pharmaceuticals, Inc. [CRVS] share price is $8.81. The Score for CRVS is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.